Tassilo Volz

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Journal: JHEP reports : innovation in hepatology

Published: August 19, 2025

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

Journal: JHEP reports : innovation in hepatology

Published: August 19, 2025

Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.

Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.

Journal: Viruses

Published: February 24, 2025

Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use.

Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 23, 2024

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells.

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells.

Journal: JHEP reports : innovation in hepatology

Published: January 19, 2024

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.

Journal: Journal of hepatology

Published: September 09, 2022

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.

Journal: JHEP reports : innovation in hepatology

Published: June 29, 2022

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system.

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system.

Journal: JHEP reports : innovation in hepatology

Published: May 04, 2021

Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.

Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.

Journal: Frontiers in microbiology

Published: February 23, 2021

Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.

Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.

Journal: Gut

Published: July 23, 2020

Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.

Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 16, 2020

Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.

Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.

Journal: Cell reports. Medicine

Published: February 13, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026